JP Morgan has advised McKesson Corporation on its strategic acquisition of a 70% stake in Community Oncology Revitalization Enterprise Ventures, LLC (Core Ventures) for $2.49 billion in cash.
Core Ventures, a subsidiary of Florida Cancer Specialists & Research Institute (FCS), specializes in business and administrative services for oncology.
This move significantly bolsters McKesson’s
All the week’s industry events straight to your inbox.
By signing up you agree to our terms of use and privacy policy.
7 Bell Yard, London, England, WC2A 2JR
You will soon receive a Reset Password link
By signing up you agree to terms of use and privacy policy.
Continue with Facebook Continue with Google